These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 33234364

  • 1. Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe-/-mice: role of SIRT1.
    Hua YQ, Zeng Y, Xu J, Xu XL.
    Phytomedicine; 2021 Jan; 81():153412. PubMed ID: 33234364
    [Abstract] [Full Text] [Related]

  • 2. Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin.
    Zeng Y, Hua YQ, Wang W, Zhang H, Xu XL.
    Biochem Pharmacol; 2020 May; 175():113927. PubMed ID: 32217100
    [Abstract] [Full Text] [Related]

  • 3. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
    Zhang J, Zhang H, Deng X, Zhang N, Liu B, Xin S, Li G, Xu K.
    Life Sci; 2018 Jan 01; 192():46-54. PubMed ID: 29158052
    [Abstract] [Full Text] [Related]

  • 4. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.
    Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM.
    World J Gastroenterol; 2019 Sep 14; 25(34):5120-5133. PubMed ID: 31558861
    [Abstract] [Full Text] [Related]

  • 5. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X, Meng Q, Wang C, Liu Z, Liu Q, Sun H, Sun P, Yang X, Huo X, Peng J, Liu K.
    Phytomedicine; 2017 Feb 15; 25():83-92. PubMed ID: 28190475
    [Abstract] [Full Text] [Related]

  • 6. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q, Weng Y, Wang S, Zhao Y, Zhang F, Zhou J, Wu X.
    Dig Dis Sci; 2018 Dec 15; 63(12):3398-3408. PubMed ID: 30191499
    [Abstract] [Full Text] [Related]

  • 7. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
    Zhang N, Wang Y, Zhang J, Liu B, Li G, Xin S, Xu K.
    Mol Med Rep; 2019 Aug 15; 20(2):1363-1372. PubMed ID: 31173200
    [Abstract] [Full Text] [Related]

  • 8. Naringenin ameliorates vascular senescence and atherosclerosis involving SIRT1 activation.
    Wang J, Wu R, Hua Y, Ling S, Xu X.
    J Pharm Pharmacol; 2023 Aug 01; 75(8):1021-1033. PubMed ID: 37343148
    [Abstract] [Full Text] [Related]

  • 9. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway.
    Chtourou Y, Fetoui H, Jemai R, Ben Slima A, Makni M, Gdoura R.
    Eur J Pharmacol; 2015 Jan 05; 746():96-105. PubMed ID: 25446569
    [Abstract] [Full Text] [Related]

  • 10. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
    Zhu M, Jia Z, Yan X, Liu L, Fang C, Feng M, Dai Y, Zhang Y, Wu H, Huang B, Li Y, Liu J, Xiao H.
    J Ethnopharmacol; 2022 Sep 15; 295():115427. PubMed ID: 35654350
    [Abstract] [Full Text] [Related]

  • 11. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency.
    Kim M, Yoo G, Randy A, Kim HS, Nho CW.
    Mol Nutr Food Res; 2017 May 15; 61(5):. PubMed ID: 27981809
    [Abstract] [Full Text] [Related]

  • 12. [Effect of pure total flavonoids from citrus on hepatic SIRT1/PGC-1alpha pathway in mice with NASH].
    Chen ZY, Li JS, Jiang JP, Yan MX, He BH.
    Zhongguo Zhong Yao Za Zhi; 2014 Jan 15; 39(1):100-5. PubMed ID: 24754177
    [Abstract] [Full Text] [Related]

  • 13. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y, Geng C, Liu X, Li M, Gao M, Liu X, Fang F, Chang Y.
    Mol Metab; 2017 Jan 15; 6(1):138-147. PubMed ID: 28123944
    [Abstract] [Full Text] [Related]

  • 14. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
    Li SW, Takahara T, Que W, Fujino M, Guo WZ, Hirano SI, Ye LP, Li XK.
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr 01; 320(4):G450-G463. PubMed ID: 33439102
    [Abstract] [Full Text] [Related]

  • 15. Tilianin alleviates lipid deposition and fibrosis in mice with nonalcoholic steatohepatitis by activating the PPARα/Nnat axis.
    Ke F, Wu X, Zheng J, Li C.
    Drug Dev Res; 2023 Aug 01; 84(5):922-936. PubMed ID: 37052239
    [Abstract] [Full Text] [Related]

  • 16. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD.
    Li J, Wang T, Liu P, Yang F, Wang X, Zheng W, Sun W.
    Food Funct; 2021 May 11; 12(9):3898-3918. PubMed ID: 33977953
    [Abstract] [Full Text] [Related]

  • 17. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.
    Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH.
    World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001
    [Abstract] [Full Text] [Related]

  • 18. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression.
    Ryu J, Kim E, Kang MK, Song DG, Shin EA, Lee H, Jung JW, Nam SH, Kim JE, Kim HJ, Son T, Kim S, Kim HY, Lee JW.
    J Pathol; 2021 Jan 07; 253(1):55-67. PubMed ID: 32918742
    [Abstract] [Full Text] [Related]

  • 19. Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα.
    Xin FZ, Zhao ZH, Zhang RN, Pan Q, Gong ZZ, Sun C, Fan JG.
    World J Gastroenterol; 2020 May 14; 26(18):2203-2220. PubMed ID: 32476787
    [Abstract] [Full Text] [Related]

  • 20. Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice.
    Liu B, Deng X, Jiang Q, Li G, Zhang J, Zhang N, Xin S, Xu K.
    Int Immunopharmacol; 2019 Oct 14; 75():105797. PubMed ID: 31421545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.